Alyeska Investment Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-297,577
Closed -$78.5M 583
2023
Q1
$78.5M Buy
297,577
+204,962
+221% +$52.1M 0.69% 42
2022
Q4
$22.2M Sell
92,615
-111,785
-55% -$25M 0.23% 140
2022
Q3
$37.6M Buy
+204,400
New +$40.7M 0.44% 75
2021
Q2
Sell
-266,089
Closed -$50.1M 770
2021
Q1
$50.1M Buy
266,089
+11,080
+4% +$1.95M 0.65% 28
2020
Q4
$41.9M Buy
+255,009
New +$37.3M 0.59% 40
2020
Q2
Sell
-4,739
Closed -$426K 524
2020
Q1
$426K Sell
4,739
-348,241
-99% -$45.1M 0.01% 336
2019
Q4
$52.2M Sell
352,980
-187,374
-35% -$25.2M 0.69% 46
2019
Q3
$65.1M Buy
540,354
+435,167
+414% +$56.2M 0.94% 23
2019
Q2
$14.2M Sell
105,187
-73,089
-41% -$9.24M 0.18% 146
2019
Q1
$23.2M Buy
178,276
+103,276
+138% +$13.9M 0.31% 106
2018
Q4
$9.33M Buy
+75,000
New +$10.1M 0.14% 178
2018
Q1
Sell
-1,171,648
Closed -$103M 471
2017
Q4
$103M Buy
+1,171,648
New +$94.1M 0.82% 33
2015
Q1
Sell
-10,200
Closed -$749K 526
2014
Q4
$749K Buy
+10,200
New +$717K 0.01% 419
2013
Q3
Sell
-50,000
Closed -$1.8M 319
2013
Q2
$1.8M Buy
+50,000
New +$1.93M 0.09% 205

Other funds holding HCA

Alyeska Investment Group's HCA Position: Q2 2023 in Review

Alyeska Investment Group sold out of HCA Healthcare (HCA) in Q2 2023, closing a stake of 297,577 shares — an estimated $78.5M sold.

Alyeska Investment Group first reported a position in HCA in Q2 2013 and held it in 14 quarters. The position peaked at $103M in Q4 2017. 1,013 funds tracked by Wall St. Rank hold HCA as of Q2 2023.

  • Alyeska Investment Group reported no remaining HCA Healthcare position as of Q2 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 297,577 HCA Healthcare shares in Q2 2023, an estimated $78.5M.
  • Alyeska Investment Group first reported a position in HCA Healthcare in Q2 2013 and held it in 14 quarters.
  • Alyeska Investment Group's HCA Healthcare position peaked at $103M in Q4 2017.
  • 1,013 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2023.

Based on Alyeska Investment Group's 13F filing for Q2 2023, filed 14 Aug 2023.